# Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

> **NCT03749733** · PHASE1 · WITHDRAWN · sponsor: **Grünenthal GmbH**

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Reference Product)
- **DRUG:** Estradiol 1.5 mg/nomegestrol acetate 2.5 mg (Test Product)

## Key facts

- **NCT ID:** NCT03749733
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2019-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749733, "Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03749733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*